Efficacy of perioperative and neoadjuvant therapies in gastric and gastroesophageal junction adenocarcinoma: a network meta-analysis
pFLOT demonstrated superior efficacy in resectable gastric/GEJ adenocarcinoma, outperforming surgery alone, nCROSS, and alternative perioperative regimens. The additive role of immunotherapy requires further investigation to optimize patient selection and outcomes.
Authors
- Irbaz Bin Riaz (ORCID: https://orcid.org/0000-0003-4249-0311)
- Muhammad Umair Anjum (ORCID: https://orcid.org/0000-0003-2429-515X)
- Muhammad Afzal (ORCID: https://orcid.org/0000-0002-5785-6067)
- Jason S. Starr (ORCID: https://orcid.org/0000-0003-4922-1392)
- Ammad Raina
- Harry H. Yoon (ORCID: https://orcid.org/0000-0001-6208-3487)
- Kunwer Sufyan Faisal (ORCID: https://orcid.org/0000-0003-0518-8711)
- Pedro Luiz Serrano Usón (ORCID: https://orcid.org/0000-0001-6122-1374)
- Mohamad Bassam Sonbol (ORCID: https://orcid.org/0000-0002-6931-242X)
- Daniel H. Ahn (ORCID: https://orcid.org/0000-0002-0161-4018)
- Syed Arsalan Ahmed Naqvi (ORCID: https://orcid.org/0000-0002-3131-2088)
- Salman Ayub Jajja
- Zhaohui Jin (ORCID: https://orcid.org/0000-0001-7844-5833)
- Tanios Bekaii-Saab (ORCID: https://orcid.org/0000-0003-4653-4537)
- Diana Segovia
Institutions
- Mayo Clinic (US)
- Hospital Israelita Albert Einstein (BR)
- Jacksonville College (US)
- Clinica Sierra Vista (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic Hospital (US)
- Mayo Clinic in Florida (US)
- Ziauddin University (PK)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1093/oncolo/oyaf157
- Citations
- 3
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 4.56